Humanwell Healthcare (Group) Co.,Ltd. (SHA:600079)
17.51
-0.18 (-1.02%)
Jul 21, 2026, 3:00 PM CST
SHA:600079 Market Cap
SHA:600079 has a market cap or net worth of 28.87 billion as of July 21, 2026. Its market cap has decreased by -20.14% in one year.
Market Cap
28.87B
Enterprise Value
35.62B
Revenue
23.93B
Ranking
n/a
PE Ratio
15.12
Stock Price
17.51
ChartMarket Cap Chart
Since January 2, 2001, SHA:600079's market cap has increased from 2.30B to 28.87B, an increase of 1,157.68%. That is a compound annual growth rate of 10.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 28.87B | -2.32% |
| Dec 31, 2025 | 29.56B | -21.41% |
| Dec 31, 2024 | 37.61B | -5.96% |
| Dec 29, 2023 | 40.00B | 4.04% |
| Dec 30, 2022 | 38.44B | 6.06% |
| Dec 31, 2021 | 36.25B | -30.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dong-E-E-Jiao | 32.33B |
| Changchun High-Tech Industry (Group) | 29.12B |
| Dizal (Jiangsu) Pharmaceutical | 28.57B |
| Shijiazhuang Yiling Pharmaceutical | 27.57B |
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 25.39B |
| Livzon Pharmaceutical Group | 25.25B |
| Betta Pharmaceuticals | 24.36B |
| Hubei Jumpcan Pharmaceutical | 24.19B |